Howard Capital Management LLC purchased a new stake in Centene Corporation (NYSE:CNC – Free Report) during the 3rd quarter, Holdings Channel reports. The firm purchased 58,241 shares of the company’s stock, valued at approximately $3,618,000.
Several other institutional investors also recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of Centene in the second quarter valued at $2,660,422,000. Wellington Management Group LLP boosted its position in shares of Centene by 423.0% during the 2nd quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock worth $853,805,000 after acquiring an additional 10,757,914 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Centene by 12.4% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,517,580 shares of the company’s stock valued at $354,173,000 after purchasing an additional 608,249 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in Centene by 21.6% in the third quarter. Assenagon Asset Management S.A. now owns 4,518,785 shares of the company’s stock valued at $302,818,000 after buying an additional 802,756 shares in the last quarter. Finally, Bank of America Corp DE acquired a new position in Centene during the second quarter worth about $285,713,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CNC has been the topic of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating on shares of Centene in a research note on Friday, October 9th. Stifel Nicolaus set a $79.00 target price on shares of Centene in a research note on Monday, August 3rd. Barclays reissued an “overweight” rating and issued a $80.00 price objective (up from $75.00) on shares of Centene in a research note on Wednesday, July 29th. Wall Street Zen upgraded shares of Centene from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 18th. Finally, HC Wainwright reissued a “buy” rating on shares of Centene in a research note on Friday, September 11th. Nine equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $70.05.
View Our Latest Analysis on Centene
Insiders Place Their Bets
In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the company’s stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the completion of the sale, the general counsel directly owned 248,854 shares in the company, valued at $16,648,332.60. This represents a 18.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.37% of the stock is owned by corporate insiders.
Centene Stock Performance
CNC traded down $1.24 during trading hours on Friday, hitting $69.27. The stock had a trading volume of 3,336,077 shares, compared to its average volume of 4,808,065. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.71. The stock has a market cap of $34.22 billion, a PE ratio of -6.64, a price-to-earnings-growth ratio of 0.44 and a beta of 1.13. Centene Corporation has a 1 year low of $31.63 and a 1 year high of $71.21. The company’s fifty day simple moving average is $65.41 and its 200 day simple moving average is $59.67.
Centene (NYSE:CNC – Get Free Report) last posted its earnings results on Monday, July 27th. The company reported $2.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%. The firm had revenue of $53.58 billion for the quarter, compared to the consensus estimate of $47.64 billion. During the same quarter in the prior year, the business posted ($0.16) earnings per share. The business’s quarterly revenue was up 9.9% on a year-over-year basis. Equities analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current year.
Centene Company Profile
Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides health insurance and related services, primarily through government-sponsored programs. Its offerings include Medicaid plans, Medicare products, health plans sold through the Affordable Care Act marketplace, and services for military families through government-sponsored healthcare programs.
The company also provides pharmacy, behavioral health, specialty healthcare, care management and administrative services through various subsidiaries and partner organizations.
See Also
- Five stocks we like better than Centene
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
- 3 Stocks Delivering Bigger Dividends Despite Market Uncertainty
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
